Loading insider details...
Beta
Latest Form 4 (Sep 22, 2026): Tax Withholding of 126,418 RNA shares, $1.13M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 22, 2026 | Atrium Therapeutics, Inc. (RNA) | Tax Withholding | 126,418 | $1.13M |
| Jun 26, 2026 | Contineum Therapeutics, Inc. (CTNM) | Grant/Award | 19,000 | n/a |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | Disposition to Issuer | 474,861 | n/a |
| Jan 23, 2026 | Avidity Biosciences, Inc. (RNA) | Sale | 6,394 | $463.2K |
| Jan 9, 2026 | Avidity Biosciences, Inc. (RNA) | Sale | 8,576 | $619.4K |
| Dec 19, 2025 | Avidity Biosciences, Inc. (RNA) | Grant/Award | 31,000 | n/a |
| Sep 5, 2025 | Avidity Biosciences, Inc. (RNA) | Exercise/Conversion | 50,000 | $62.0K |
| Aug 29, 2025 | Avidity Biosciences, Inc. (RNA) | Exercise/Conversion | 25,000 | $31.0K |
| Jun 26, 2025 | Contineum Therapeutics, Inc. (CTNM) | Grant/Award | 14,750 | n/a |
| Mar 21, 2025 | Avidity Biosciences, Inc. (RNA) | Sale | 31,540 | $979.6K |